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Background: Congenital Heart Disease (CHD) is the commonest group of congenital 
malformations and affects 7-8 per 1000 live born newborns. Nevertheless, it is estimated that more 
than 50% of babies with undiagnosed CHD are not detected by routine neonatal cardiac 
examination. 
Aim: To find the incidence of CHD in newborns and to determine the accuracy of pulse oximetry 
for detecting clinically unrecognized critical congenital heart disease (CCHD) in the newborns. 
Methods: Pulse oximetry was performed on clinically normal newborns within 4 hours of first day 
of life. Inclusion criteria: All newborns who were admitted in postnatal ward & Neonatal Intensive 
care unit (NICU). Exclusion criteria: babies and neonates with a prenatal diagnosis of duct 
dependent circulation. If oxygen saturation (SpO2) was below 90%, then echocardiography was 
performed. 
Results: During the study period, 4926 live born neonates were examined. Nine out of 12 neonates 
with SpO2<90% had CCHD. Four neonates had tetralogy of Fallot (TOF), two had tricuspid atresia, 
two had transposition of great arteries (TGA) and one had truncus arteriosus. The incidence of CHD 
was 33.49 per 1000 live births and CCHD was 1.82 per 1000.  A pulse oximetry cut-off value of 
below 90% for detecting CCHD showed 90% sensitivity, 99.94% specificity, 75% positive 
predictive value (PPV) and 99.98% negative predictive value (NPV).  
Conclusion: Pulse oximetry is safe, feasible and noninvasive and also used to screen for CCHD. It 









Congenital cardiovascular malformations are the commonest type of birth defects, occurring in 7 to 
8 per 1000 live births and are responsible for most mortality in the first year of life.1,2 One quarter 
of these children will have complex congenital heart disease (CCHD), which requires surgery or 
catheter intervention in the first year of life.3 Neonates with such unrecognized CCHD can manifest 
with profound metabolic acidosis, intracranial hemorrhage, hypoxic-ischemic encephalopathy, 
necrotizing enterocolitis, cardiac failure, cardiovascular collapse and even death. Early surgical 
interventional therapies have contributed to declining levels of morbidity and mortality due to 
CCHD. Delayed detection or failure to diagnose CCHD continues to cause poor neurological 
outcomes and avoidable deaths.4 Heart murmurs are one of the clinical finding of noncritical heart 
disease typically diagnosed on cardiac examination. However, many times these may be absent 
because of the underlying anatomy, prolonged decline of pulmonary vascular resistance or reduced 
ventricular function.5-8 Pulse oximetry is a universal tool for detecting and differentiating preductal 
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and post-ductal hypoxemia.9 Large number of studies have reported a high sensitivity and 
specificity for pulse oximetry for early detection of CCHD in newborn babies.5-12 Pulse oximetry 
screening could provide improvements in CHD case detection and management. Clinical evaluation 
though mandatory can miss out the diagnosis as the findings or may be too subtle in the initial 24 
hours of life. This study was designed to find the incidence of CHD and early detection of CCHD 
by pulse oximetry in a rural hospital. 
 
Material & Methods 
This hospital-based prospective study was conducted in the Neonatology Unit of Pediatric 
Department at Acharya Vinoba Bhave Rural Hospital (AVBRH), Sawangi Meghe, Wardha from 
August 2013 to February 2015. All newborns delivered in these hospital including preterm babies 
were included in the study. Neonates with a prenatal diagnosis of duct dependent circulation by 
fetal echocardiography and out-born babies were excluded. An informed consent was obtained from 
one of the parents (preferably by mother) before initial screening and the purpose of the screening 
was explained to them. The measurements of SpO2 were performed using a Massimo Single 
Extraction Technology (SET) handheld pulse oximeter with a neonatal reusable Nellcor SpO2 
sensor OXI-A/N probe. SpO2 was measured within the first 4 hours of life by a trained social 
worker on all the limbs of the newborn. The pulse oximetry probe was held manually to the palm or 
wrist and to the sole, following a random order and measured the saturation (Figure 1). 
 
 
Figure 1. Measurement of SpO2 by Pulse oximetry in newborns 
 
 
Any screening saturation SpO2 ≥95% and saturation difference between right upper limb and lower 
limb was <3% was considered as normal. If the saturation difference between right upper limb and 
lower limb was ≥3%, then echocardiography was done. If the SpO2 was between 90-94%, clinical 
examination was performed. If suspicious of CHD, the neonate was referred for echocardiography. 
If no suspicion of CHD, then saturation was repeated after 6 hours and echocardiography done if 
SpO2 ≤95. When the saturation was ≤90%, echocardiography was performed. The definition which 
was used in our study is as follows: 
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• CCHD defines as lesions that include cyanotic defects such as pulmonary atresia, TGA, truncus 
arteriosus, Fallot’s tetralogy (TOF), total anomalous pulmonary venous return (TAPVR), and 
tricuspid atresia, as well as left-sided obstructive lesions, including critical aortic stenosis, 
coarctation of the aorta,  interrupted aortic arch, and hypoplastic left heart syndrome.  
• Non-critical CHD was defined as any ASD >5mm, PDA>2mm, VSD, valvular pulmonary 
stenosis, aortic stenosis and pulmonary artery branch stenosis.  
• Normal variants were patent foramen ovale or ASD <5 mm and PDA <2 mm.  
 
For all newborns, clinical examination was performed with a special emphasis to signs and 
symptoms related to the cardiovascular system to detect CHD. The presence of central cyanosis, 
abnormal peripheral pulses, abnormal precordium, heart murmurs on cardiac auscultation, 
tachypnoea, and chest retractions were considered as positive clinical examination findings more 
suggestive of CHD.9 The neonates with positive clinical examination also underwent 
echocardiography.  
 
The study protocol was approved by the ethical committees of the JNMC Institute. 
 
Statistical analysis: All statistical analyses were performed using SPSS 16 statistical software. The 
diagnostic accuracy of pulse oximetry for detecting the CCHD was measured by computation of 






A total number of 4926 (Male: 2510; Female: 2416) live born neonates were examined at AVBRH, 
Sawangi Meghe. Pulse Oximetry screening was performed on all newborns. There were 12 
neonates with saturation < 90%, 24 neonates with saturation between 90-95% and 4890 neonates 
with saturation >95%. Nine out of 12 neonate with SpO2<90% had CCHD (TOF:4, Tricuspid 
atresia:2, TGA:2 and one had truncus arteriosus). One neonate who had severe coarctation of aorta 
was not diagnosed by pulse oximetry. Out of 24 with saturation 90-95%, 19 neonates showed 
normal saturation when repeated after 6 hours of initial measurement. Five neonates still showed 
afall in SpO2. Of these two had CHD, one a VSD and one am atrioventricular septal defect. A 
flowchart showing the distribution of neonates based on pulse oximetry screening for detection of 
CCHD in shown in figure 2.  
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Figure 2. Flowchart showing distribution of neonates based on pulse oximetry screening for 




There were 165 neonates with CHD in this study period, the incidence was 33.49 per 1000 live 
births and CCHD was 1.82 per 1000. A total of 106 patients (2.1%) had positive clinical evaluation, 
the most common being a murmur. Clinical evaluation was positive in only 3 patients with CCHD 
and 32 patients with non-critical CHD. The common non-critical CHD were PDA (n=89), VSD 
(n=48) and ASD (n=17). For detecting CCHD, a cut-off value of below 90% saturation showed 
90% sensitivity, 99.94% specificity, 75% PPV and 99.98% NPV. Whereas cut-off value of below 
95% saturation showed 90% sensitivity, 99.84% specificity, 52.94% PPV and 99.98% NPV. The 




Congenital heart disease is one of the commonest human malformations, accounting for 10% of 
infant deaths and about 50% of deaths from malformations.1 Delayed diagnosis of CHD is 
associated with a worse preoperative condition.2 In our study the incidence was 33.49 per 1000 live 
birth which is higher than the earlier reported study from various population-based studies.3-5  
PDA was the most common CHD followed by VSD found in our study. Fernanda Cruz De et al9 
reported 9 (0.23%) cases with CHD in their study in 4,027 newborns. In another study done by 
Mathur NB et al11, found 72(7.57%) cases with CHD out of 950 screened cases. The incidence of 
CCHD varies from study to study, depending on the CCHD definition and the number of different 
cardiac defects included in the study.10T he incidence of CCHD was 1.82 per 1000 live birth in our 
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study agrees with a previous study.6-7 This is mostly because of detection of cardiac lesions due to 
use of echocardiography for screening of all suspicious babies. All live newborns were eligible for 
this study, irrespective of gestational age or admission to a NICU. The initial presentation of CHD 
could mimic septicemia, respiratory distress or other conditions.11-14 The symptoms of progressive 
cardiac failure, such as sweating, feeding difficulty, fast breathing and failure to thrive, are 
nonspecific in early neonatal periods. The cardiovascular examination of the neonate is important 
for diagnosing CHD especially murmurs, cyanosis and abnormal heart rate.  
 
Ainsworth et al reported that the neonatal examination detects only 44% of cardiac malformations 
which present in infancy. He also concluded that if a murmur is heard there is a 54% chance of 
there being an underlying cardiac malformation. Bakr AF et al12 detected 46% CHD with clinical 
examination and 31% by pulse oximetry detecting, resulting in a combined sensitivity of 77% with 
99.7% specificity.  
 
Screening newborns with non-invasive measurement of oxygen saturation has been accepted for 
early detection of CCHD. Vaidyanathan B et al3 mentioned a poor sensitivity for pulse oximetry, 
for detection of CHD. Koppel RI et al6 reported the effectiveness of pulse oximetry screening for 
CHD in asymptomatic newborns with sensitivity of 60%; specificity: 99.95%; PPV: 75%; NPV: 
99.98% and accuracy of 99.97%. Our study showed a very good sensitivity and but PPV was less 
than optimal to detect CCHD. Results of present study were comparable to the study done by 
Arlettazet et al.15 
 
Similarly, de Wahl Granelli A et al16found that systematic screening for CCHD with high accuracy 
required a latest generation pulse oximeter, and saturation from the right hand and one foot 
substantially improves the CCHD detection (Sensitivity: 98.5%; specificity: 96.0%; PPV: 89.0% 
and NPV: 99.5%).  
 
Thangaratinam et al17 completed a meta-analysis that included 13 studies and reported a specificity 
of 99.9% and a false positive rate (FPR) of 0.05%. Riede et al2 reported foot pulse oximetry in 
41,445 births and demonstrated a sensitivity of 77.8% and FPR of 0.1%. In contrast, de-Wahl 
Granelli et al4 conducted simultaneous pre-ductal and post-ductal oximetry in 39,821 births with a 
sensitivity of 62% and a FPR of 0.17 %. Whereas Richmond et al5 showed that repeat pulse 
oximetry brought their FPR down from 5% to 1%. In our study, for detecting CCHD, pulse 
oximetry cut-off value of below 90% for detecting CCHD showed 90% sensitivity, 99.94% 
specificity, 75% PPV and 99.98% NPV.  
 
Pulse oximetry is a noninvasive, inexpensive, and useful tool that will detect the CCHD cases. 
Earlier diagnosis may lead to earlier interventions and improved neonatal outcomes. However, 
studies have mentioned the limitations of clinical examination in early detection of infants with 
CCHD. The clinical examination limitations include lack of specificity of neonatal heart murmurs, 
absence of any cardiac findings including murmur in nearly half of all infants with CCHD, and 
limited pediatrician experience in discriminating innocent from pathological murmurs. Also, studies 
have clearly reported that the visual assessment of cyanosis is suboptimal.19-20 Echocardiography is 
the gold standard for diagnosis of CHD but it is not feasible and readily available as a routine 
screening tool in developing countries.21-23 This study suggests that the presence of abnormal 
clinical signs such as murmurs should warrant an urgent cardiac evaluation.  
 
Also, pulse oximetry may potentially emerge as a useful adjunct to clinical evaluation, especially 
for CHD. In the developing country, clinical evaluation and pulse oximetry after birth has increased 
the chances of detection of CHD.3 An abnormal screening warrants prompt echocardiography. The 
major strengths of our study are the large number of babies prospectively screened for CHD. 
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Thus, this study concluded that the pulse oximetry screening is a simple, noninvasive test use in 
clinically normal newborns, for early detection of CCHD. Also, a detail physical examination along 
with pulse oximetry screening in the neonates will provide clues to the diagnosis of CHD.  
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